Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy — two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to the ingredients needed to copy popular weight-loss medications.
Ticker: Hims & Hers drops plans for knockoff weight loss pill; Washington Post editor steps down
